Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-21

FDA Approved: PRAZOSIN HYDROCHLORIDE — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved the original ANDA for prazosin hydrochloride from Biocon Pharma Inc., enabling a generic version of the antihypertensive medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin hydrochloride (prazosin hydrochloride)

Snippet

ORIG AP for PRAZOSIN HYDROCHLORIDE (PRAZOSIN HYDROCHLORIDE)